MicroRNA-128 regulates cell cycle, chromosomal stability and DNA repair of mitomycin C-treated lung cancer cells through repressing nonerythroid αII spectrin.

Zhang Rui,Jing Ying,Zhang Haiyang,Liu Chang,Niu Yahan,Wang Jin,Yang Jie,Zen Ke,Zhang Junfeng,Zhang Chen-Yu,Li Donghai
DOI: https://doi.org/10.18632/oncotarget.5817
2015-01-01
Oncotarget
Abstract:Mitomycin C (MMC), a potent DNA crosslinker, are used as a chemotherapeutic agent by virtue of majorly causing DNA interstrand cross-links (DNA ICLs) of cancer cells. While microRNAs are grossly dysregulated in human cancers and may serve as oncogenes or tumor suppressors, less is known about their functional roles in MMC-treated lung cancer. Here, we report that miR-128 can damage the repair of DNA ICLs via targeting nonerythroid αII spectrin (αII Sp) to cause cell cycle arrest and to promote chromosomal aberrations of lung cancer cells treated with MMC. Firstly, αII Sp was a conserved target of miR-128 by computational predictions and experimental validations. Secondly, miR-128 caused translational inhibition of αII Sp and the decrease of αII Sp protein level. Also, miR-128 induced cell cycle arrest and chromosomal instability by repressing αII Sp. Finally, miR-128 significantly influenced the interaction of αII Sp/FANCA/XPF complex to limit their DNA repair. In summary, these findings demonstrate that miR-128 accelerates cell cycle arrest and chromosomal instability of MMC-treated lung cancer cells by suppressing αII Sp, and could be applied for adjuvant chemotherapy of lung cancer.
What problem does this paper attempt to address?